These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22831829)

  • 41. Ipratropium bromide added to asthma treatment in the pediatric emergency department.
    Zorc JJ; Pusic MV; Ogborn CJ; Lebet R; Duggan AK
    Pediatrics; 1999 Apr; 103(4 Pt 1):748-52. PubMed ID: 10103297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Images in clinical medicine. Nebulizer-associated anisocoria.
    Iosson N
    N Engl J Med; 2006 Mar; 354(9):e8. PubMed ID: 16510741
    [No Abstract]   [Full Text] [Related]  

  • 43. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
    Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
    Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
    Eaton B; Hall J; MacDonald S
    Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
    [No Abstract]   [Full Text] [Related]  

  • 45. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
    Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
    Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease.
    Guleria R; Singh TR; Sinha S; Padhy K; Gupta K; Pande JN
    Indian J Chest Dis Allied Sci; 2003; 45(4):241-6. PubMed ID: 12962458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Salbutamol and ipratropium in COPD.
    Harrison M; Murphy R
    Emerg Med J; 2001 Mar; 18(2):118. PubMed ID: 11300184
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination.
    Shneerson JM
    Respiration; 1986; 50 Suppl 2():274-5. PubMed ID: 2951820
    [No Abstract]   [Full Text] [Related]  

  • 50. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Nebulised ipratropium bromide and bronchiolitis.
    Smith M; al Zarad M
    J Accid Emerg Med; 1999 Nov; 16(6):443-4. PubMed ID: 10572820
    [No Abstract]   [Full Text] [Related]  

  • 51. Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia.
    Schilero GJ; Hobson JC; Singh K; Spungen AM; Bauman WA; Radulovic M
    J Spinal Cord Med; 2018 Jan; 41(1):42-47. PubMed ID: 27808011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ikeda A; Nishimura K; Izumi T
    Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
    [No Abstract]   [Full Text] [Related]  

  • 53. Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned.
    Smith TJ; Coyne P; French W; Ramakrishnan V; Corrigan P
    J Palliat Med; 2009 Sep; 12(9):771-2. PubMed ID: 19719370
    [No Abstract]   [Full Text] [Related]  

  • 54. Treating hyperkalaemia.
    Lexchin J
    Lancet; 2003 Feb; 361(9357):616. PubMed ID: 12598176
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.
    Wilkie RA; Bryan MH
    J Pediatr; 1987 Aug; 111(2):278-82. PubMed ID: 2956405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD.
    Mahler DA; Fierro-Carrion G; Mejia-Alfaro R; Ward J; Baird JC
    Med Sci Sports Exerc; 2005 Apr; 37(4):529-35. PubMed ID: 15809548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
    Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Niewoehner DE; Lapidus R; Cote C; Sharafkhaneh A; Plautz M; Johnson P; Kesten S
    Pulm Pharmacol Ther; 2009 Dec; 22(6):587-92. PubMed ID: 19737620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.